Search results
Results from the WOW.Com Content Network
The index includes companies in pharmaceuticals, equipment and supplies, health-care providers and biotechnology, among others. 5-year returns (annualized): 12.4 percent Expense ratio: 0.09 percent
If you want to see more stocks in this selection, check out 5 Best Pharma Dividend Stocks To Buy. As per a Bloomberg report dated September 12, the global bio-pharma market was valued at $274.10 ...
The company's shares have been southbound for the better part of three years. And despite major regulatory wins since late 2023, the biotech hasn't recovered: The stock is down 23% year to date ...
But on Dec. 18, pharmaceutical giant Merck (NYSE: MRK) announced its intentions to dip its toes into the fast-growing anti-obesity field. It penned an agreement with Hansoh Pharma, a China-based ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
8. BioMarin Pharmaceutical. Specialty biotech BioMarin Pharmaceutical (NASDAQ: BMRN) is another phenomenal company that can help fatten up investor's portfolios in 2025. Even though new ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Bioverativ Inc. is an American multinational biotechnology company that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia. [3] Bioverativ competes with Baxalta (acquired by Shire Plc in 2016 [ 4 ] ), Pfizer and Novo Nordisk . [ 2 ]